Fierce Pharma Layoff Tracker 2024. The sankey diagram below highlights the web of factors driving the 2024 biotech layoffs for select companies, from operational changes to clinical failures. According to data gathered by fierce biotech, a total of 187 biopharma layoffs were recorded last year.

The precision oncology biotech is laying off 30% of staff as it prioritizes pushing its lead solid tumor candidate toward a phase 2 trial in the coming. Last year, we tallied 187 total layoffs among biotech companies, a 57% jump compared to 119 in 2022.